TABLE 1.
Characteristics of the included trials.
| References | Country | Type of groups | Number of participants | Randomization and blinding | PNB technique | Observation time of pain | Quality assessment |
| Di Giuseppe et al. (21) | Switzerland | SP + PNB | 23 | 1:1 ratio; double-blind | Ultrasound guided | 6, 12, 24, and 48 h | Good |
| SP | 26 | ||||||
| Rajabi et al. (20) | Iran | GA + PNB | 30 | 1:1:1 ratio; double-blind | Anatomic landmarks | 12 h | Good |
| GA | 30 | ||||||
| GA + placebo PNB | 30 | ||||||
| Imbelloni et al. (19) | >Brazil | SP + PNB | 100 | >1:1 ratio; double-blind | >Under nerve stimulation | >6, 12, 18, 24, and 30 h | >Good |
| SP | 100 | ||||||
| Naja et al. (18) | Lebanese | GA + PNB | 30 | 1:1:1 ratio; double-blind | Under nerve stimulation | 6 h, 12 h, 24 h, 36 h, 48 h, 3 days, 4 days, 5 days, and 6 days | Good |
| GA | 30 | ||||||
| GA + placebo PNB | 30 | ||||||
| Brunat et al. (17) | France | GA + PNB | 25 | 1:1 ratio; double-blind | Anatomic landmarks | 1, 2, 4, 8, 12, and 24 h | Good |
| GA | 27 | ||||||
| Luck and Hewett (16) | Australia | GA + PNB + LA | 10 | 1:1 ratio; double-blind | Anatomic landmarks | 0.5, 2, 4, and 24 h | Good |
| GA + LA | 10 |